CIP2A, cellular inhibitor of PP2A, 57650

N. diseases: 141; N. variants: 1
Disease: Stomach Carcinoma ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma 		0.070 AlteredExpression disease BEFREE We thus assessed whether CIP2A expression is associated with sensitivity of GC to DDP. 29103022 2018
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma 		0.070 Biomarker disease BEFREE Further in vivo studies are warranted to explore the biological role of CIP2A and its interaction with JNK2 signaling in gastric cancer. 24398514 2014
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma 		0.070 AlteredExpression disease BEFREE The regulation of c-MYC and CIP2A expression is characterized by a positive feedback mechanism facilitating the expression of both of them and accelerating cancer cell proliferation in gastric cancer. 23925667 2013
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma 		0.070 Biomarker disease BEFREE Cancerous inhibitor of PP2A (CIP2A) is a recently described inhibitor of PP2A in breast and gastric cancer. 21490338 2011
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma 		0.070 Biomarker disease BEFREE MYC-dependent regulation and prognostic role of CIP2A in gastric cancer. 19470954 2009
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma 		0.070 AlteredExpression disease BEFREE Normal and malignant gastric tissues derived from 37 patients with gastric cancer were analyzed for CIP2A expression using reverse transcription-PCR and immunohistochemical staining. 18559589 2008
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma 		0.070 Biomarker disease BEFREE Together with other cancer associated auto-antibodies such as anti-p53, anti-p62, anti-Koc, and anti-CENP-F, auto-antibodies to p90 represent a new marker for tumors such as HCC and gastric cancer. 12118381 2002